D-1247-2014 Class III Terminated

Recalled by GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline — Aiken, SC

Recall Details

Product Type
Drugs
Report Date
April 30, 2014
Initiation Date
February 20, 2014
Termination Date
January 20, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
150 cases

Product Description

Nicorette Lozenge and NicoDerm CQ, nicotine polacrilex system. 189 2mg Mint Flavored Lozenges + 21 31 mg Patches. OTC Only. GlaxoSmithKlein, 1000 GSK Drive, Moon Township, PA 15108. UPC: 0-03-0766-1480-30-2.

Reason for Recall

Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.

Distribution Pattern

U.S. Nationwide

Code Information

Lot #13L05N, Expiry: 8/15